Home › Glycogen Storage Disease Type II › New York › New York City
Glycogen Storage Disease Type II clinical trials in New York City, NY
4 studies for Glycogen Storage Disease Type II are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
RecruitingPhase 1/2
- NYU Langone, New York
Pompe Disease Registry Protocol
RecruitingObservational study
- Icahn School of Medicine at Mount Sinai- Site Number : 840005, New York
- Metropolitan Hospital Center- Site Number : 840110, New York
- Columbia University Irving Medical Center- Site Number : 840125, New York
Pompe Pregnancy Sub-Registry
RecruitingObservational study
- New York University School Of Medicine- Site Number : 840040, New York
- Mt. Sinai School of Medicine- Site Number : 840005, New York
- Columbia University Irving Medical Center- Site Number : 157199, New York
A Global Prospective Observational Registry of Patients With Pompe Disease
RecruitingObservational study
- NYU Neurogenetics, NYU Langone Medical Center, New York
Glycogen Storage Disease Type II trials in other cities
- Durham, NC8 studies
- Irvine, CA5 studies
- Arlington, VA5 studies
- St. Louis, MO5 studies
- Atlanta, GA4 studies
- Pittsburgh, PA4 studies
- Philadelphia, PA4 studies
- Cincinnati, OH3 studies
- Indianapolis, IN3 studies
- Jacksonville, FL3 studies
- Phoenix, AZ3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.